Micronized Purified Flavonoid Fraction in Pretreating CABG Patients

Sirlak M., AKAR A. R., Eryilmaz S., Cetinkanat E. K., ÖZÇINAR E., Kaya B., ...More

TEXAS HEART INSTITUTE JOURNAL, vol.37, no.2, pp.172-177, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 2
  • Publication Date: 2010
  • Journal Name: TEXAS HEART INSTITUTE JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.172-177
  • Keywords: Biological markers, cardiopulmonary bypass/adverse effects, flavonoids/administration & dosage, hesperidin/therapeutic use, reperfusion injury/drug therapy, ACUTE CORONARY SYNDROMES, HAMSTER-CHEEK POUCH, DAFLON 500 MG, REPERFUSION INJURY, INFLAMMATORY MEDIATORS, LEUKOCYTE ADHESION, BIOMARKERS, ISCHEMIA/REPERFUSION, DISEASE, TERM
  • Ankara University Affiliated: Yes

Abstract

The aim of the present study was to determine whether oral pretreatment with micronized purified flavonoid fraction (Dation) has beneficial effects on cardiac function and outcome after cardiac operations.